1303-21: Pharmacologic Treatment of Bipolar Depression: Moving Beyond the Standard Paradigm
- Registration Closed
Internet Explorer does not cooperate with this site. Please see below for options that work with APNA eLearning.*
1303-21: Pharmacologic Treatment of Bipolar Depression: Moving Beyond the Standard Paradigm
This presentation will provide an overview of evidence-based pharmacologic treatment options for bipolar depression. The use of non-traditional agents will be discussed, and participants will be able to enhance their knowledge of treatment options that can be used when standard treatments are ineffective or cause intolerable side effects.
Presenters: Lyons Hardy, PMHNP; Brian McCarthy, MSN
Disclosures: The APNA planners and faculty have no relevant financial relationships to disclose. Off-label uses will be discussed during this presentation.
Session Length: 1 hour 30 minutes
Target Audience: APRN
Learning Outcome:
Upon completion of this presentation, the participant will be able to:
- Discuss evidence-based pharmacologic treatment options for bipolar depression.
Keywords: Bipolar Depression, Pharmacology, Depression
Nursing Continuing Professional Development:
1.5 pharmacology contact hours. * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.
The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Originally Presented
APNA 35th Annual Conference
Access to this course will end: December 1, 2024
*For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.